Pharmacology News

The FDA announced that it has approved Brixadi, an extended-release subcutaneous injection for the treatment of moderate to severe opioid use disorder.

SEATTLE — Using a more robust diagnostic “continuum” for UTIs could improve the diagnosis and treatment of the most common hospital-acquired infection, according to a study.

The U.S. Supreme Court unanimously ruled in favor of Regeneron and Sanofi that two of Amgen’s patents for PCSK9 inhibitor technology were invalid, allowing alirocumab to stay on the U.S. market.

A 76-year-old man makes an appointment for an evaluation of shakiness.

A monoclonal antibody was shown to speed the time to viral suppression in heavily treatment-experienced people with HIV compared with ART regimens that did not contain it, according to a study.

SAN DIEGO — “Now more than ever,” physicians need to manage opioid use disorder with pharmacological treatment in the primary care setting, according to a speaker at the ACP Internal Medicine Meeting.

A network-based model demonstrated that men who have sex with men drive the Neisseria gonorrhoeae epidemic and that intensive screening in the low-risk population had little impact on decreasing transmission rates.

The U.S. Drug Enforcement Agency, or DEA, has announced a temporary extension of prescribing flexibility for controlled substances over telehealth, which was set to expire on May 11.

About half of adults who were prescribed schedule II-controlled stimulants were concurrently exposed to other central nervous system-active drugs, many of which have withdrawal effects, complicating discontinuation, researchers reported.

SAN DIEGO — ACP has launched a new initiative to improve equitable access to obesity care through physician education, advocacy and partnerships.